These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26205955)

  • 21. Increased expression of carbonic anhydrase IX in oral submucous fibrosis and oral squamous cell carcinoma.
    Yang JS; Chen MK; Yang SF; Chang YC; Su SC; Chiou HL; Chien MH; Lin CW
    Clin Chem Lab Med; 2014 Sep; 52(9):1367-77. PubMed ID: 24695043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of carbonic anhydrase IX overexpression in stage III non-small cell lung cancer patients after neoadjuvant treatment.
    Ibis K; Saglam S; Saglam EK; Firat P; Yilmazbayhan D; Toker A; Ozkan B; Hancer VS; Buyukdogan M; Disci R; Pilanci KN
    Pathol Res Pract; 2018 Sep; 214(9):1291-1296. PubMed ID: 30029935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High level of circulating vitamin D during neoadjuvant therapy may lower risk of metastatic progression in high-risk rectal cancer.
    Abrahamsson H; Porojnicu AC; Lindstrøm JC; Dueland S; Flatmark K; Hole KH; Seierstad T; Moan J; Redalen KR; Meltzer S; Ree AH
    BMC Cancer; 2019 May; 19(1):488. PubMed ID: 31122213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selecting patients for hyperthermia combined with preoperative chemoradiotherapy for locally advanced rectal cancer.
    Kim SW; Yea JW; Kim JH; Gu MJ; Kang MK
    Int J Clin Oncol; 2018 Apr; 23(2):287-297. PubMed ID: 29134362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantification of carbonic anhydrase IX expression in serum and tissue of renal cell carcinoma patients using enzyme-linked immunosorbent assay: prognostic and diagnostic potentials.
    Zhou GX; Ireland J; Rayman P; Finke J; Zhou M
    Urology; 2010 Feb; 75(2):257-61. PubMed ID: 19963243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbonic Anhydrase IX Expression and Treatment Response Measured in Rectal Adenocarcinoma Following Neoadjuvant Chemo-Radiotherapy.
    Bádon ES; Beke L; Mokánszki A; András C; Méhes G
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision.
    Govindarajan A; Reidy D; Weiser MR; Paty PB; Temple LK; Guillem JG; Saltz LB; Wong WD; Nash GM
    Ann Surg Oncol; 2011 Dec; 18(13):3666-72. PubMed ID: 21590450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer.
    Atkins M; Regan M; McDermott D; Mier J; Stanbridge E; Youmans A; Febbo P; Upton M; Lechpammer M; Signoretti S
    Clin Cancer Res; 2005 May; 11(10):3714-21. PubMed ID: 15897568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C).
    Dewdney A; Cunningham D; Tabernero J; Capdevila J; Glimelius B; Cervantes A; Tait D; Brown G; Wotherspoon A; Gonzalez de Castro D; Chua YJ; Wong R; Barbachano Y; Oates J; Chau I
    J Clin Oncol; 2012 May; 30(14):1620-7. PubMed ID: 22473163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbonic anhydrase IX in bladder cancer: a diagnostic, prognostic, and therapeutic molecular marker.
    Klatte T; Seligson DB; Rao JY; Yu H; de Martino M; Kawaoka K; Wong SG; Belldegrun AS; Pantuck AJ
    Cancer; 2009 Apr; 115(7):1448-58. PubMed ID: 19195047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relation between carbonic anhydrase IX serum level, hypoxia and radiation resistance of head and neck cancers].
    Rosenberg V; Pastoreková S; Zaťovičová M; Slezák P; Waczulíková I; Svec J
    Klin Onkol; 2014; 27(4):269-75. PubMed ID: 25115716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic release of osteoprotegerin during oxaliplatin-containing induction chemotherapy and favorable systemic outcome of sequential radiotherapy in rectal cancer.
    Meltzer S; Kalanxhi E; Hektoen HH; Dueland S; Flatmark K; Redalen KR; Ree AH
    Oncotarget; 2016 Jun; 7(23):34907-17. PubMed ID: 27145458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of carbonic anhydrase IX suggests poor outcome in rectal cancer.
    Korkeila E; Talvinen K; Jaakkola PM; Minn H; Syrjänen K; Sundström J; Pyrhönen S
    Br J Cancer; 2009 Mar; 100(6):874-80. PubMed ID: 19240720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MRI predictive factors for tumor response in rectal cancer following neoadjuvant chemoradiation therapy--implications for induction chemotherapy?
    Yu SK; Tait D; Chau I; Brown G
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):505-11. PubMed ID: 24074924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Randomized Phase 2 Study of Neoadjuvant Chemoradiaton Therapy With 5-Fluorouracil/Leucovorin or Irinotecan/S-1 in Patients With Locally Advanced Rectal Cancer.
    Jung M; Shin SJ; Koom WS; Jung I; Keum KC; Hur H; Min BS; Baik SH; Kim NK; Kim H; Lim JS; Hong SP; Kim TI; Roh JK; Park YS; Ahn JB
    Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1015-22. PubMed ID: 26581140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.
    Smith JJ; Chow OS; Gollub MJ; Nash GM; Temple LK; Weiser MR; Guillem JG; Paty PB; Avila K; Garcia-Aguilar J;
    BMC Cancer; 2015 Oct; 15():767. PubMed ID: 26497495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Response of CAIX and CAXII to in vitro re-oxygenation and clinical significance of the combined expression in NSCLC patients.
    Ilie M; Hofman V; Zangari J; Chiche J; Mouroux J; Mazure NM; Pouysségur J; Brest P; Hofman P
    Lung Cancer; 2013 Oct; 82(1):16-23. PubMed ID: 23910904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short- and Long-Term Quality of Life and Bowel Function in Patients With MRI-Defined, High-Risk, Locally Advanced Rectal Cancer Treated With an Intensified Neoadjuvant Strategy in the Randomized Phase 2 EXPERT-C Trial.
    Sclafani F; Peckitt C; Cunningham D; Tait D; Giralt J; Glimelius B; Keränen SR; Bateman A; Hickish T; Tabernero J; Thomas J; Brown G; Oates J; Chau I
    Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):303-12. PubMed ID: 26031368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Hypoxic Response Expression as a Survival Biomarkers in Treatment-Naive Advanced Breast Cancer.
    Gunawan I; Hatta M; Benyamin AF; Islam AA
    Asian Pac J Cancer Prev; 2020 Mar; 21(3):629-637. PubMed ID: 32212787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer.
    Hussain SA; Ganesan R; Reynolds G; Gross L; Stevens A; Pastorek J; Murray PG; Perunovic B; Anwar MS; Billingham L; James ND; Spooner D; Poole CJ; Rea DW; Palmer DH
    Br J Cancer; 2007 Jan; 96(1):104-9. PubMed ID: 17213826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.